Dermatology Handbook
For UK audiences

The professionals guide to product selection

Search

Results

Ultralanum
Zeon

Ultralanum

Ultralanum plain cream and ointment both contain the active ingredient fluocortolone, which is a type of medicine known as a topical corticosteroid. Corticosteroids are medicines used for reducing inflammation. When fluocortolone is applied to the skin it works by acting inside the skin cells to decrease the release of these inflammatory substances. This reduces swelling, redness and itch.
Boots Derma Care Itch Relief
Boots

Boots Derma Care Itch Relief

Boots Derma Care Itch Relief cream contains crotamiton for effective relief of itching and works for 10 hours
Surcare Sensitive
McBride

Surcare Sensitive

A laundry and washing-up liquid brand which contains no enzymes, dyes, acids or fragrances. The Surcare range includes laundry powder, laundry liquid, laundry capsules, fabric conditioner and washing-up liquid.
Cavilon No Sting Barrier Film
Solventum (KCI Medical)

Cavilon No Sting Barrier Film

Protective, transparent barrier film. Alcohol-free formulation is pain-free on broken skin and provides up to 72 hours’ protection before re-application. Non-cytotoxic.
Cavilon Durable Barrier Cream
Solventum (KCI Medical)

Cavilon Durable Barrier Cream

Highly concentrated barrier cream to protect against bodily fluids and moisturise skin. Provides long-lasting protection from skin breakdown.
Cavilon Continence Care Wipes
Solventum (KCI Medical)

Cavilon Continence Care Wipes

No-rinse skin wipes for the treatment of incontinence-associated dermatitis (IAD). The wipes contain 3% dimethicone and are biodegradable, pH balanced, perfume- and paraben-free, soft and hypoallergenic.
Guselkumab (Tremfya)
Janssen-Cilag

Guselkumab (Tremfya)

Guselkumab is a human IgG1λ monoclonal antibody (mAb) that binds selectively to the interleukin 23 (IL-23) protein with high specificity and affinity. IL-23, a regulatory cytokine, affects the differentiation, expansion and survival of T cell subsets and innate immune cell subsets, which represent sources of effector cytokines, including IL-17A, IL-17F and IL-22 that drive inflammatory disease. Levels of IL-23 are elevated in the skin of patients with plaque psoriasis. In in vitro models, guselkumab was shown to inhibit the bioactivity of IL-23 by blocking its interaction with cell surface IL-23 receptor, disrupting IL-23-mediated signaling, activation and cytokine cascades. Guselkumab exerts clinical effects in plaque psoriasis through blockade of the IL-23 cytokine pathway.
Ustekinumab (Stelara)
Janssen-Cilag

Ustekinumab (Stelara)

Ustekinumab is a fully human IgG1κ monoclonal antibody that binds with specificity to the shared p40 protein subunit of human cytokines interleukin (IL)-12 and IL-23. Ustekinumab inhibits the bioactivity of human IL-12 and IL-23 by preventing p40 from binding to the IL-12Rβ1 receptor protein expressed on the surface of immune cells. Ustekinumab cannot bind to IL-12 or IL-23 that is already bound to IL-12Rβ1 cell surface receptors. Thus, ustekinumab is not likely to contribute to complement- or antibody-mediated cytotoxicity of cells with IL-12 and/or IL-23 receptors.
Pevaryl
Janssen-Cilag

Pevaryl

Pevaryl contains econazole nitrate, which is a broad-spectrum antimycotic with activity against dermatophytes, yeasts and moulds. A clinically relevant action against Gram-positive bacteria has also been found
Nizoral
Janssen-Cilag

Nizoral

Nizoral contains ketoconazole, which has a potent antimycotic action against dermatophytes and yeasts. Ketoconazole cream acts rapidly on pruritus, which is commonly seen in dermatophyte and yeast infections